Skip to main content

Table 1 Repeatability of MALDI MS results obtained on antibody-modified GNP-ITO in 6 patient serum samples (accepting insulin therapy)

From: Immune-enrichment of insulin in bio-fluids on gold-nanoparticle decorated target plate and in situ detection by MALDI MS

 

Mear (MS intensity)

CV% for within day

CV% for between day

Patient 1

2.50

15.8

17.0

Patient 2

4.52

13.8

14.8

Patient 3

4.11

14.1

15.3

Patient 4

3.28

15.0

15.3

Patient 5

4.47

11.1

14.6

Patient 6

3.67

15.1

16.0

  1. Ten replicate measurements per sample per day were performed for 3 days to generate 30 values per sample
Back to article page

Clinical Proteomics

ISSN: 1559-0275